Pay in 4 interest-free payments of $5.96 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
"The American taxpayers will be getting their money back." The companies pledged to offer their blockbuster obesity and Type 2 diabetes drugs to Medicare and Medicaid programs for $245 a month, with copays for Medicare beneficiaries set at $50 a month starting in April
Voltage-dependent K+ channels in pancreatic beta cells: Role, regulation and potential as therapeutic targets
Can My Doctor Request a Peer-to-peer Review
Neuroprotective effect of reduced glutathione on cisplatin-based chemotherapy in advanced gastric cancer: A randomised double-blind placebo-controlled trial
US$ 20.66
US$ 29.81
US$ 26.80
US$ 27.37
US$ 21.58
